Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.4K Buy
200
+100
+100% +$34.2K 0.04% 98
2026
Q1
$35.2K Hold
100
0.02% 133
2025
Q4
$32.7K Hold
100
0.02% 125
2025
Q3
$28.2K Hold
100
0.02% 130
2025
Q2
$27.9K Hold
100
0.02% 126
2025
Q1
$31.2K Hold
100
0.02% 119
2024
Q4
$26.1K Buy
+100
New +$29.7K 0.02% 129

Other funds holding AMGN

Pinney & Scofield's AMGN Position: Q2 2026 in Review

Pinney & Scofield increased its Amgen (AMGN) stake by 100% in Q2 2026, buying an estimated $34.2K and bringing the position to 200 shares worth $72.4K. The position accounts for 0.04% of the portfolio, ranked #98.

Pinney & Scofield first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pinney & Scofield held 200 shares of Amgen worth $72.4K as of Q2 2026.
  • Pinney & Scofield bought 100 Amgen shares in Q2 2026, an estimated $34.2K.
  • Amgen made up 0.04% of Pinney & Scofield's portfolio in Q2 2026, its #98 holding.
  • Pinney & Scofield first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pinney & Scofield's 13F filing for Q2 2026, filed 7 Aug 2026.